El amor es una de las emociones más poderosas y complejas experimentadas por los seres humanos. A lo largo de la historia, el amor ha sido un tema esencial en la poesía, canciones y obras de arte, pero ¿alguna vez te has preguntado cuál es el origen biológico de es …
La visión es uno de los sentidos más impresionantes y complejos que poseemos los seres vivos. A través de nuestros ojos, percibimos el mundo que nos rodea y capturamos detalles que nos ayudan a comprender mejor nuestro entorno. La resolución óptica es un aspecto fu …
La resolución óptica: Explorando la visión animal y el poder del ojo humano Read More »
Zura Bio Limited, a multi-asset clinical-stage biotechnology company focused on developing novel medicines for immune and inflammatory disorders, announced the final closing of a private placement resulting in gross proceeds to Zura Bio of approximately $80 million.
ISA Pharmaceuticals B.V. presented the first clinical data of the combination of ISA101b and Regeneron’s anti-PD-1 Libtayo® at the ASCO annual meeting in Chicago.
Ascentage Pharma announced that it has released preliminary results from a Phase Ib/II study of the Bcl-2 inhibitor, lisaftoclax, as a monotherapy or combined with ibrutinib or rituximab in patients with Waldenström macroglobulinemia, in a Poster Presentation at the 59th American Society of Clinical Oncology Annual Meeting that marked the first data readout from a
Telix Pharmaceuticals Limited advises that Dr Christian Behrenbruch, Managing Director and Group CEO, will be presenting at the Jefferies Healthcare Conference being held in New York from June 7 to June 9, 2023.
Telix to Present at Jefferies 2023 Healthcare Conference Read More »
Transgene and NEC Corporation announced that new data have been presented on TG4050, an individualized neoantigen cancer vaccine, at the American Society of Clinical Oncology Annual Meeting in Chicago, IL. TG4050 is based on Transgene’s myvac® platform and powered by NEC’s cutting-edge AI capabilities.
OSE Immunotherapeutics SA presented a poster and a publication in abstract book featuring Tedopi®, an immunotherapy activating tumor specific T-cells, in non-small cell lung cancer and in ovarian cancer at the 2023 American Society of Clinical Oncology Annual Meeting held June 2 – 6.
Ascentage Pharma announced that for the second consecutive year, it has released updated data of APG-2449, a novel FAK/ALK/ROS1 tyrosine kinase inhibitor developed by Ascentage Pharma, in patients with non-small cell lung cancer, in a Poster Discussion session at the 59th American Society of Clinical Oncology Annual Meeting.
DeepX Diagnostics Inc. announced that its digital dermatoscope DermoSightTM received clearance from the US Food and Drug Administration for teledermatology screening of suspect skin cancer lesions in the United States.
